awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33763305-2508B1DB-E80D-4ECC-B1D4-DBFE68160FF9
Q33763305-2508B1DB-E80D-4ECC-B1D4-DBFE68160FF9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33763305-2508B1DB-E80D-4ECC-B1D4-DBFE68160FF9
Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus.
P2860
Q33763305-2508B1DB-E80D-4ECC-B1D4-DBFE68160FF9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33763305-2508B1DB-E80D-4ECC-B1D4-DBFE68160FF9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c67b4274880353c2ef06d2f1ad22d35f86f5d1d
P2860
Efficacy and safety of canagliflozin alone or as add-on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52-week open-label study.